KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Capital Employed (2021 - 2025)

Ginkgo Bioworks Holdings filings provide 5 years of Return on Capital Employed readings, the most recent being 29.79% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 1256.0% to 29.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.79%, a 1256.0% increase, with the full-year FY2025 number at 27.35%, up 1223.0% from a year prior.
  • Return on Capital Employed hit 29.79% in Q4 2025 for Ginkgo Bioworks Holdings, up from 31.8% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 10.8% in Q3 2021 to a low of 202.63% in Q3 2022.
  • Median Return on Capital Employed over the past 5 years was 51.39% (2023), compared with a mean of 67.31%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -19183bps in 2022 and later skyrocketed 15656bps in 2023.
  • Ginkgo Bioworks Holdings' Return on Capital Employed stood at 92.53% in 2021, then decreased by -17bps to 108.71% in 2022, then skyrocketed by 53bps to 51.39% in 2023, then increased by 18bps to 42.34% in 2024, then rose by 30bps to 29.79% in 2025.
  • The last three reported values for Return on Capital Employed were 29.79% (Q4 2025), 31.8% (Q3 2025), and 26.88% (Q2 2025) per Business Quant data.